CRDL:CA Stock

Leede Financial analyst Douglas Loe cut his target on Cardiol Therapeutics (Cardiol Therapeutics Sto... Read More

Leede Financial analyst Douglas Loe maintained a “Speculative Buy” rating and $11.00 target on C... Read More

Following the company’s receipt of positive clinical data, Leede Jones Gable analyst Douglas L... Read More

Following the release of new preclinical data, Leede Jones Gable analyst Douglas Loe remains upbeat ... Read More

Following news from the company, Leede Jones Gable analyst Douglas Loe remains bullish about Cardiol... Read More